Bigbear Pharmaceutical·Medication Guide

• ​Selumetinib Dosage Adjustments for Adverse Reactions

  Selumetinib Dosage Adjustments for Adverse ReactionsIf intolerance persists after two dose reductions, permanently discontinue.Dose Reduction Scheme B···【Read More】

  Update: 2026-07-06Source: Haiou HealthViews: 109

• Indications for Selumetinib

  Selumetinib dosage and administration: What is the dosage of Selumetinib? The dosage is based on body surface area (BSA). The usual recommended dose i···【Read More】

  Update: 2026-07-03Source: Haiou HealthViews: 106

• Can sotorasib be used during pregnancy and breastfeeding? What precautions should be taken?

  For pregnant and lactating patients, if Sotorasib is to be used, it should be strictly in accordance with the doctor's advice, and do not use the ···【Read More】

  Update: 2026-07-03Source: Haiou HealthViews: 118

• Sotorasib Daily Precautions

  Sotorasib Daily PrecautionsWhat daily precautions should be taken during Sotorasib treatment? It is important to actively maintain contact with your d···【Read More】

  Update: 2026-07-03Source: Haiou HealthViews: 101

• ​Mechanism of Action of Sotorasib

  Mechanism of Action of SotorasibIrreversibly and selectively inhibits KRASG12C mutation, selectively inhibits KRAS signaling and cell growth in vitro,···【Read More】

  Update: 2026-07-03Source: Haiou HealthViews: 108

• Drug Interactions with Sotorasib

  Sotorasib is the first approved KRAS G12C-targeted therapy, indicated for the treatment of non-small cell lung cancer and colorectal cancer with KRAS ···【Read More】

  Update: 2026-07-03Source: Haiou HealthViews: 96

• ​Side Effects of Sotorasib

  Side Effects of SotorasibHematologicVery common (≥10%): lymphopenia (up to 48%), decreased hemoglobin (up to 43%), prolonged activated partial thrombo···【Read More】

  Update: 2026-07-03Source: Haiou HealthViews: 107

• Serious Side Effects of Sotorasib

  Use of Sotorasib may cause a range of side effects, some of which are serious and require prompt medical attention. During treatment with Sotorasib, c···【Read More】

  Update: 2026-07-02Source: Haiou HealthViews: 110

• Dose Adjustment for Sotorasib Adverse Reactions

  If adverse reactions occur, a maximum of 2 dose reductions are permitted: first dose reduction, 480 mg orally once daily; second dose reduction, 240 m···【Read More】

  Update: 2026-07-01Source: Haiou HealthViews: 118

• Sotorasib Usual Adult Dose

  Sotorasib is indicated for patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC) who have received at leas···【Read More】

  Update: 2026-06-30Source: Haiou HealthViews: 115

• How much does Lao Big Bear generic abemaciclib cost?

  For HR-positive, HER2-negative breast cancer patients, the abemaciclib (BESIDX) from Lao Big Bear Pharmaceutical not only continues the clinical value···【Read More】

  Update: 2026-06-25Source: Haiou HealthViews: 127

• What are the purchasing channels for Lao Big Bear version of abemaciclib (Abemaciclib)

  As an important alternative to the original drug, the abemaciclib generic (BESIDX) produced by Lao Big Bear Pharmaceutical has entered the market at a···【Read More】

  Update: 2026-06-25Source: Haiou HealthViews: 120

• Is there a Lao generic version of Abemaciclib?

  Abemaciclib, marketed under the brand name BESIDX by Bigbear Pharma in Laos, is a CDK4/6 selective inhibitor indicated for hormone receptor (HR)-posit···【Read More】

  Update: 2026-06-25Source: Haiou HealthViews: 130

• How much does Lao Big Bear version Lorlatinib cost?

  As a legitimate generic version of Lorlatinib officially approved for marketing by the Lao Ministry of Health, LORLADX (100mg×30 tablets/box) manufact···【Read More】

  Update: 2026-06-25Source: Haiou HealthViews: 124

• What are the purchasing channels for Lao Big Bear version of lorlatinib (Lorlatinib)

  Against the backdrop of prohibitively high targeted drug costs that deter many patients, the lorlatinib generic (trade name LORLADX) launched by Lao B···【Read More】

  Update: 2026-06-25Source: Haiou HealthViews: 132